Lombard Medical, is a medical device company focused on the $1.8bn market for minimally invasive treatment of abdominal aortic aneurysms (AAAs). The Company has global regulatory approval for Aorfix?, an endovascular stent graft which has been specifically designed to treat patients with the broadest range of AAA anatomies, including aortic neck angulation up to 90 degrees. The Company has also achieved CE Mark for the Altura? endograft system, an innovative ultra-low profile endovascular stent graft that offers a simple and predictable solution for the treatment of more standard AAA anatomies.
Intelligent systems make vascular surgery ever safer, more exciting and more efficient. Endovascular interventions with lower radiation exposure, computer-assisted operation planning, robot-assisted surgery, EDP-controlled neuromonitoring, perioperative "on demand pain management": artificial intelligence has already found its way into our everyday medical life - whether you have already noticed it or not. However, our patients do not want automated medicine alone. You need care, understanding and empathy. Technology, artificial intelligence and empathetic attention are not contradictory. Rather, they complement each other. This exciting, future-oriented topic is to be the focus of our annual conference in 2020 in ...
10th MUNICH VASCULAR CONFERENCE (MAC)
on 09-11 December 2020.
The 10th MAC will continue to be a platform for mutual exchange between vascular clinicians from all vascular medical specialties and colleagues from translational and basic research. Both sides will benefit from each other: clinicians have the chance to learn more about translational research and the evolution of cutting-edge technologies and translational researchers may get a better understanding for the needs of clinicians and their patients.